Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

18 results
Display

Treatment of Classic Kaposi's Sarcoma Showing a Discretely Scattered Distribution with Intralesional Vinblastine Injections

Kim BR, Park JT, Byun SY, Kwon SH, Huh CH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of M-VAC(Methotrexate, Vinblastine, Adriamycin and Cisplatin) Chemotherapy in Locally Invasiue T3a/T3b) Transitional Cell Carcinoma of the Bladder

Yoon HN, Chae SG, Jeon HS, Park WS, Choi HR, Yoon HS

  • KMID: 2290277
  • Korean J Urol.
  • 1998 Dec;39(12):1217-1221.
PURPOSE: Since a significant number of patients with locally invasive bladder tumor(T3a/T3b) subsequently develop distant metastases, there have been lots of controversies in deciding treatment modalities. In the past decade,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Inappropriate ADH Secretion Secondary to Vinblastine Therapy

Park EH, Cho HS, Yoo HS, Lyu CJ, Yang CH, Kim KY

  • KMID: 2104416
  • J Korean Pediatr Soc.
  • 1998 Oct;41(10):1430-1432.
Inappropriate secretion of antidiuretic hormone (ADH) secondary to vincristine therapy has been reported frequently. But there has been five previous reports of vinblastine associated SIADH in the world and in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Postoperative Sequential Mitomycin-C, Vinblastine, and Cisplatin (MVP) Chemotherapy and Radiotherapy for Resected Stage II-IIIA Non-small Cell Lung Cancer

Kim TW, Lee JS, Jung BH, Yun HJ, Zang DY, Lee JH, Kim SB, Kim SW, Suh C, Lee KH, Kim WK, Kim WD, Kim JH, Choi EK, Chang H, Kim DK, Park SI, Sohn KH, Kim SH

  • KMID: 2251441
  • Korean J Med.
  • 1998 May;54(5):607-614.
OBJECTIVES: The poor survival rates among patients receiving surgery alone for stages II and III non-small cell lung cancer prompted several trials of adjuvant therapy after resection. We performed a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Neoadjuvant Chemotherapy with 5-Fluorouracil (5-FU), Vinblastine and Cisplatin (FVP) for Stage III Non-Small Cell Lung Cancer (NSCLC)

Won JI, Chun JH, Kim HJ, Jo MS, Kim DK, Kwak YT, Kim JS, Choi SJ, Kim SR

  • KMID: 2059148
  • J Korean Cancer Assoc.
  • 1997 Oct;29(5):807-815.
PURPOSE: As the prognosis of stage III NSCLC is still poor with or without operation, we conducted a phase II trial of neoadjuvant chemotherapy (CHT) with 5-FU, vinblastine, cisplatin prior...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Medroxyprogesterone Acetate On Cytotoxicity of Vinblastine in Renal Cell Carcinoma Cell Lines

Lee DH, Chung BH, Hong SJ

  • KMID: 1914473
  • Korean J Urol.
  • 1997 Jan;38(1):1-6.
Inadequate effectiveness of anticancer drug in treating renal cell carcinoma has been attributed to the overexpression of multidrug resistance gene (MDR1) and its product, membrane-bound P-glycoprotein. P-glycoprotein is known to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neoadjuvant M-VAC (Methotrexate, Vinblastine, Adriamycin and Cisplatin) Effect on the Invasive Bladder Tumor

Oh JH, Ryu SB

  • KMID: 2290086
  • Korean J Urol.
  • 1996 Mar;37(3):293-300.
We evaluated the effect of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in 63 patients with invasive transitional cell carcinoma of the bladder between January 1987 and December 1993. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
M-VAC(Methotrexate, Vinblastine, Doxorubicin and Cisplatinum) Chemotherapy for Metastatic Transitional Cell Carcinoma

Sin CC, Chang SG, Kim JI

  • KMID: 2139365
  • Korean J Urol.
  • 1995 May;36(5):502-506.
We treated 23 patients with metastatic transitional cell carcinoma with methotrexate, vinblastine, doxorubicin and cisplatinum(M-VAC) chemotherapy from March 1989 to June 1994. The mean age of the patients was 60.0...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Verapamil and Cyclosporin A on Cytotoxic Effect of Vinblastine upon Human Renal Cell Carcinoma Cell Lines

Kim HG, Kim HH, Lee C

  • KMID: 1913987
  • Korean J Urol.
  • 1995 Mar;36(3):231-240.
It is well known that renal cell carcinoma shows poor responses upon chemotherapy, and a multidrug-resistance has been suggested as one of the possible mechanisms of their resistances to chemotherapeutics...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Mitomycin-c, Vinblastine, and Cisplatin(MVP) Combined Chemotherapy in Non-Small Cell Lung Cancer

Kim YW, Park NH, Ji SK, Choi HM, Lee SH, Lee KH, Jang TW, Jung MH

BACKGROUND: Despite advances in chemotherapy, the treatment of inoperable non-small cell carcinoma of the lung remains poor. According to the recent reports, the response rates of mitomycin, vinblastine, and cisplatin(MVP)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The effect of adjuvant M-VAC(methtrexate, vinblastine, doxorubicin and cisplatin) chemotherapy on advanced transitional cell carcinoma of the upper urinary tract

Seo BW, Ha DB, Park CH, Lee SC

  • KMID: 2060396
  • Korean J Urol.
  • 1992 Aug;33(4):632-636.
We treated 11 patients with advanced transitional cell carcinoma of upper urinary tract with adjuvant M-VAC chemotherapy and their median survival time was compared with 9 patients without M-VAC chemotherapy...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of combination therapy with vinblastine, adriamycin and interferon-alpha, gamma on human renal cell carcinoma cell lines

Lee ES, Kim HH, Ahn HJ, Min KJ, Lee C

  • KMID: 2060393
  • Korean J Urol.
  • 1992 Aug;33(4):611-617.
In vitro study was performed to evaluate the effect of combination therapy with vinblastine. adriamycin and interferon-alpha, gamma on human renal cell carcinoma cell lines. Three renal cell carcinoma cell...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Palliative chemotherapy of soft tissue sarcoma with adriamycin and dacarbazine(ADIC) and cyclophosphamide, vinblastine, adriamycin and dacarbazine(CYVADIC)

Park YS, Kang WK, Suh CI, Kim HT, Kim HJ, Park KC, Heo DS, Bang YJ, Kim NK

  • KMID: 1742159
  • J Korean Cancer Assoc.
  • 1992 Jun;24(3):401-410.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Preliminary results of M-VAC(methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for advanced trasitional cell carcinoma of the urothelium

Jung SY, Kim SW, Yoon JY, Cho YH, Yoon MS, Lim SK

  • KMID: 1912838
  • Korean J Urol.
  • 1991 Feb;32(1):31-36.
We reviewed retrospectively 23 patients treated with M-VAC (Methotrexate. Vinblastine, Doxorubicin, Cisplatin) from October 1987 to June 1990 at our hospital to evaluate predictive variables for response to chemotherapy and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of M-VAC (Methotrexate, vinblastine, Doxorubicin and cisplatin) Chemotherapy for Metastatic Transitional Cell Carcinoma of the bladder Preliminary Report

Lee KS, Paick JS, Lee C, Kim SW

  • KMID: 2289663
  • Korean J Urol.
  • 1990 Oct;31(5):648-654.
We treated 15 patients with metastatic transitional cell carcinoma with methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) chemotherapy. Median patient age was 58 years. The site of primary lesion was bladder...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Preliminary Results of Neoadjuvant M-VAC(Methotrexate, Vinblastine, Adriamycin, Cisplatin) Chemotherapy for Bladder Carcinoma

Shin CS, Ryu SB

  • KMID: 2139591
  • Korean J Urol.
  • 1990 Feb;31(1):59-64.
The trend in chemotherapy of bladder carcinoma has evolved from the single agent to the combination chemotherapy. In 1985 Sternberg et al. reported 71 per cent of significant tumor regression...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of M-VAC(Methotrexate, Vinblastine, Doxorubicin and Cisplatin) Regimen on Experimental Animal: Histopathological Study

Kim SJ, Kim WJ, Kim YK

  • KMID: 2139584
  • Korean J Urol.
  • 1990 Feb;31(1):14-22.
Histopathologic study was performed to observe the effects of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin), widely used for advanced bladder cancer and its metastatic lesion, on the visceral organs of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
M-VAC(Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Urothelial Tumors

Lee KS, Park CH, Lee SC

  • KMID: 2289517
  • Korean J Urol.
  • 1989 Jun;30(3):340-344.
Patients with advanced urothelial tumors that relapse or persist following conventional therapy have poor prognosis. Management of the patients with recurrent local or disseminated urothelial tumors presents a difficult clinical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr